{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:09:13Z","timestamp":1790309353977,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003802","name":"University Research Committee, University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.chembiol.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T15:36:07Z","timestamp":1757086567000},"page":"1150-1165.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A covalent inhibitor targeting Cys16 on RhoA in colorectal cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Tin-Yan","family":"Koo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Ying Ki","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nga-Sze","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary Yui-Yan","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ianto Bosheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yu","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen H.N.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suet Yi","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive Yik-Sham","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2025.08.004_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010033","article-title":"CREPT Promotes Melanoma Progression Through Accelerated Proliferation and Enhanced Migration by RhoA-Mediated Actin Filaments and Focal Adhesion Formation","volume":"12","author":"Liu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.chembiol.2025.08.004_bib2","doi-asserted-by":"crossref","first-page":"32574","DOI":"10.1074\/jbc.M604338200","article-title":"The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization","volume":"281","author":"Yang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2025.08.004_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2025.08.004_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ng.2984","article-title":"Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma","volume":"46","author":"Kakiuchi","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2025.08.004_bib5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.chembiol.2025.08.004_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ng.2983","article-title":"Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer","volume":"46","author":"Wang","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2025.08.004_bib7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/2159-8290.CD-19-0811","article-title":"Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.chembiol.2025.08.004_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/1541-7786.MCR-08-0248","article-title":"RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors","volume":"7","author":"Zhang","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.chembiol.2025.08.004_bib9","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-09-1541","article-title":"Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone","volume":"69","author":"Liu","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2025.08.004_bib10","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1158\/0008-5472.CAN-04-1136","article-title":"Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors","volume":"64","author":"Wang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2025.08.004_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52746-w","article-title":"Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling","volume":"9","author":"Kalpana","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2025.08.004_bib12","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1038\/ncomms6458","article-title":"RHOA inactivation enhances Wnt signalling and promotes colorectal cancer","volume":"5","author":"Rodrigues","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.08.004_bib13","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3892\/ijo.2015.3281","article-title":"RhoA is associated with invasion and poor prognosis in colorectal cancer","volume":"48","author":"Jeong","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib14","first-page":"599","article-title":"NCCN Guidelines Updates: Management of Metastatic Colorectal Cancer","volume":"17","author":"Messersmith","year":"2019","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.chembiol.2025.08.004_bib15","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.chembiol.2025.08.004_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.chembiol.2025.08.004_bib17","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1242\/jcs.01582","article-title":"Rho signalling at a glance","volume":"117","author":"Schwartz","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.chembiol.2025.08.004_bib18","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1038\/onc.2016.473","article-title":"Rho GTPases: Anti- or pro-neoplastic targets?","volume":"36","author":"Zandvakili","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2025.08.004_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4161\/sgtp.25131","article-title":"Dynamic functions of RhoA in tumor cell migration and invasion","volume":"4","author":"O'Connor","year":"2013","journal-title":"Small GTPases"},{"key":"10.1016\/j.chembiol.2025.08.004_bib20","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1038\/srep06449","article-title":"The three-way switch operation of Rac1\/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition","volume":"4","author":"Huang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2025.08.004_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/1471-2407-12-469","article-title":"Vincristine enhances amoeboid-like motility via GEF-H1\/RhoA\/ROCK\/Myosin light chain signaling in MKN45 cells","volume":"12","author":"Eitaki","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.chembiol.2025.08.004_bib22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3892\/ijo.2017.4093","article-title":"Rho GTPases as therapeutic targets in cancer","volume":"51","author":"Cardama","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2004.06.028","article-title":"Induction by lysophosphatidic acid of peritoneal and pleural metastases of intestinal cancers induced by azoxymethane in Wistar rats","volume":"219","author":"Tatsuta","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.chembiol.2025.08.004_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1756-9966-29-123","article-title":"Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo","volume":"29","author":"Wang","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2025.08.004_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21037\/jgo-23-844","article-title":"Activation of RhoA\/ROCK2 signaling by hypoxia-inducible factor 1alpha in promoting tumor growth and metastasis in human colon cancer","volume":"15","author":"Du","year":"2024","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10585-007-9119-1","article-title":"Rho GTPases: functions and association with cancer","volume":"24","author":"Ellenbroek","year":"2007","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.chembiol.2025.08.004_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chembiol.2012.05.009","article-title":"Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases","volume":"19","author":"Shang","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib28","article-title":"Covalent Inhibitors Allosterically Block the Activation of Rho Family Proteins and Suppress Cancer Cell Invasion","volume":"7","author":"Sun","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.chembiol.2025.08.004_bib29","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1158\/1541-7786.MCR-19-0024","article-title":"Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA-NF-kappaB","volume":"17","author":"Zhu","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.chembiol.2025.08.004_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.trecan.2022.12.001","article-title":"Preclinical to clinical utility of ROCK inhibitors in cancer","volume":"9","author":"Barcelo","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.chembiol.2025.08.004_bib31","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00066-019-01476-z","article-title":"Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy : TROD 09-001 multi-institutional study","volume":"195","author":"Ozyigit","year":"2019","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib32","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4103\/1673-5374.335827","article-title":"Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.chembiol.2025.08.004_bib33","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s43018-020-00116-1","article-title":"FoxM1 insufficiency hyperactivates Ect2-RhoA-mDia1 signaling to drive cancer","volume":"1","author":"Limzerwala","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.chembiol.2025.08.004_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9010035","article-title":"Rhosin Suppressed Tumor Cell Metastasis through Inhibition of Rho\/YAP Pathway and Expression of RHAMM and CXCR4 in Melanoma and Breast Cancer Cells","volume":"9","author":"Tsubaki","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.chembiol.2025.08.004_bib35","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nature08622","article-title":"Novel mutant-selective EGFR kinase inhibitors against EGFR T790M","volume":"462","author":"Zhou","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2025.08.004_bib36","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2025.08.004_bib37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nchembio.1817","article-title":"Prolonged and tunable residence time using reversible covalent kinase inhibitors","volume":"11","author":"Bradshaw","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib38","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41589-021-00786-7","article-title":"Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo","volume":"17","author":"Dubiella","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41589-020-0550-9","article-title":"Identification of a potent and selective covalent Pin1 inhibitor","volume":"16","author":"Pinch","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature18002","article-title":"Proteome-wide covalent ligand discovery in native biological systems","volume":"534","author":"Backus","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2025.08.004_bib41","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1038\/s41467-023-41894-3","article-title":"Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2","volume":"14","author":"Ramachandran","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.08.004_bib42","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2025.08.004_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ijch.202300029","article-title":"Activity-based protein profiling - finding general solutions to specific problems","volume":"63","author":"Cravatt","year":"2023","journal-title":"Isr. J. Chem."},{"key":"10.1016\/j.chembiol.2025.08.004_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41589-018-0060-1","article-title":"Identification of a S. aureus virulence factor by activity-based protein profiling (ABPP)","volume":"14","author":"Lentz","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.75.101304.124125","article-title":"Activity-based protein profiling: from enzyme chemistry to proteomic chemistry","volume":"77","author":"Cravatt","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.chembiol.2025.08.004_bib46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41587-020-00778-3","article-title":"Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries","volume":"39","author":"Kuljanin","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.chembiol.2020.09.001","article-title":"Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC","volume":"28","author":"Boike","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib48","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.1021\/jacs.0c04527","article-title":"Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity","volume":"142","author":"Panyain","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2025.08.004_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202311190","article-title":"Discovery of a Potent Deubiquitinase (DUB) Small-Molecule Activity-Based Probe Enables Broad Spectrum DUB Activity Profiling in Living Cells","volume":"62","author":"Conole","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2025.08.004_bib50","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/acscentsci.9b01268","article-title":"Light-Activatable, 2,5-Disubstituted Tetrazoles for the Proteome-wide Profiling of Aspartates and Glutamates in Living Bacteria","volume":"6","author":"Bach","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.chembiol.2025.08.004_bib51","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41589-023-01527-8","article-title":"Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity","volume":"20","author":"Chiu","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib52","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chembiol.2023.04.004","article-title":"CysDB: a human cysteine database based on experimental quantitative chemoproteomics","volume":"30","author":"Boatner","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.08.004_bib53","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1038\/s41467-023-41844-z","article-title":"Chemoproteomic capture of RNA binding activity in living cells","volume":"14","author":"Heindel","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.08.004_bib54","doi-asserted-by":"crossref","first-page":"35308","DOI":"10.1074\/jbc.M704426200","article-title":"AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling","volume":"282","author":"Shibolet","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2025.08.004_bib55","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Tan","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.chembiol.2025.08.004_bib56","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/acs.biochem.7b01113","article-title":"Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele","volume":"57","author":"Zhang","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2025.08.004_bib57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/21541248.2018.1438024","article-title":"Shedding new light on RhoA signalling as a drug target in vivo using a novel RhoA-FRET biosensor mouse","volume":"11","author":"Nobis","year":"2020","journal-title":"Small GTPases"},{"key":"10.1016\/j.chembiol.2025.08.004_bib58","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature04665","article-title":"Spatiotemporal dynamics of RhoA activity in migrating cells","volume":"440","author":"Pertz","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2025.08.004_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/cells10010066","article-title":"Rho GTPases as Key Molecular Players within Intestinal Mucosa and GI Diseases","volume":"10","author":"Pradhan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.chembiol.2025.08.004_bib60","first-page":"2028","article-title":"Upregulated STAT3 and RhoA signaling in colorectal cancer (CRC) regulate the invasion and migration of CRC cells","volume":"20","author":"Zhang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.chembiol.2025.08.004_bib61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2025.08.004_bib62","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10585-005-3585-0","article-title":"Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth","volume":"22","author":"Morimoto-Tomita","year":"2005","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.chembiol.2025.08.004_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/bjc.2017.420","article-title":"Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer","volume":"118","author":"Dopeso","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.chembiol.2025.08.004_bib64","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/s41467-018-04607-9","article-title":"Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer","volume":"9","author":"Nam","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.08.004_bib65","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41467-017-01107-0","article-title":"Asymmetric localization of DLC1 defines avian trunk neural crest polarity for directional delamination and migration","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.08.004_bib66","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.1105718","article-title":"Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity","volume":"307","author":"Ozdamar","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2025.08.004_bib67","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1016\/j.ejmech.2010.07.031","article-title":"Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities","volume":"45","author":"Wang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.chembiol.2025.08.004_bib68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/chir.23027","article-title":"Absolute configuration and biological profile of pyrazoline enantiomers as MAO inhibitory activity","volume":"31","author":"Goksen","year":"2019","journal-title":"Chirality"},{"key":"10.1016\/j.chembiol.2025.08.004_bib69","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2025.08.004_bib70","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2025.08.004_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.419","article-title":"A Comprehensive Guide for Assessing Covalent Inhibition in Enzymatic Assays Illustrated with Kinetic Simulations","volume":"2","author":"Mons","year":"2022","journal-title":"Curr. Protoc."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945625002557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945625002557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:06:57Z","timestamp":1758614817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945625002557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2451945625002557"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2025.08.004","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A covalent inhibitor targeting Cys16 on RhoA in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}